All Posts Tagged Tag: ‘Daiichi Sankyo’

Lung Cancer Drug Trial Cancelled

This week, ArQule, a biotechnology company focused on developing “next-generation” small-molecule cancer drugs, announced that a drug trial for a lung cancer treatment it developed has been stopped early. The independent Data Monitoring Committee (DMC) overseeing the Phase 3 trial recommended that the study be halted following an interim analysis that concluded the trial would not show improved overall survival …

Read More